Evotec

EvotecEvotec
Evotec

Evotec

Life science company pioneering drug discovery with AI and advanced technologies.

DR 69Speed 321993Active4837Hamburg, Germany
Rate

About

Evotec is a life science company pioneering drug discovery and preclinical development. They accelerate the journey from concept to cure by leveraging cutting-edge technology, disruptive science, and disease knowledge, working across modalities from small molecules to biotherapeutics. Evotec serves partners in the pharmaceutical and biotechnology industries, aiming to make high-quality therapies more accessible and affordable.
Frequently asked

What does Evotec do?

Evotec is a life science company pioneering drug discovery and preclinical development. They accelerate the journey from concept to cure by leveraging cutting-edge technology, disruptive science, and disease knowledge, working across modalities from small molecules to biotherapeutics. Evotec serves partners in the pharmaceutical and biotechnology industries, aiming to make high-quality therapies more accessible and affordable.

What is Evotec's revenue?

StartupHub estimates Evotec's annual revenue at $1.1B (range $595.2M to $2.0B, 66% confidence), based on comparable companies in the sector.

What is Evotec's valuation?

StartupHub estimates Evotec's effective valuation at $106.5M (range $67.3M to $161.4M, 10% confidence), based on comparable companies in the sector.

How much funding has Evotec raised?

Evotec has raised a total of $27M in funding. The most recent round on record is Series A.

Where is Evotec headquartered?

Evotec is headquartered in Hamburg, Germany.

When was Evotec founded?

Evotec was founded in 1993.

What industry does Evotec operate in?

Evotec operates in Drug Discovery, Biotech, AI-Driven Drug Discovery, Life Sciences, Pharmaceutical Services, R&D Services.

How many employees does Evotec have?

Evotec has approximately 4837 people on record.

HEADCOUNT
4837
DOMAIN RATING
69
Comments

No comments yet. Be the first to share your take.